203 related articles for article (PubMed ID: 21515423)
1. Oxidative stress-associated shape transformation and membrane proteome remodeling in erythrocytes of end stage renal disease patients on hemodialysis.
Antonelou MH; Kriebardis AG; Velentzas AD; Kokkalis AC; Georgakopoulou SC; Papassideri IS
J Proteomics; 2011 Oct; 74(11):2441-52. PubMed ID: 21515423
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.
Georgatzakou HT; Tzounakas VL; Kriebardis AG; Velentzas AD; Papageorgiou EG; Voulgaridou AI; Kokkalis AC; Antonelou MH; Papassideri IS
Eur J Haematol; 2017 Jun; 98(6):590-600. PubMed ID: 28295628
[TBL] [Abstract][Full Text] [Related]
4. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
Olszewska M
Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
6. Alterations of erythrocyte structure and cellular susceptibility in patients with chronic renal failure: effect of haemodialysis and oxidative stress.
Brzeszczynska J; Luciak M; Gwozdzinski K
Free Radic Res; 2008 Jan; 42(1):40-8. PubMed ID: 18324522
[TBL] [Abstract][Full Text] [Related]
7. Effects of pre-storage leukoreduction on stored red blood cells signaling: a time-course evaluation from shape to proteome.
Antonelou MH; Tzounakas VL; Velentzas AD; Stamoulis KE; Kriebardis AG; Papassideri IS
J Proteomics; 2012 Dec; 76 Spec No.():220-38. PubMed ID: 22796353
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell calcium homeostasis in patients with end-stage renal disease.
Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
[TBL] [Abstract][Full Text] [Related]
9. Effects of peritoneal-and hemodialysis on levels of plasma protein and lipid oxidation markers in diabetic patients.
Sozer V; Korkmaz Guntas G; Konukoglu D; Dervisoglu E; Gelisgen R; Tabak O; Kalender B; Uzun H
Minerva Med; 2013 Feb; 104(1):75-84. PubMed ID: 23392540
[TBL] [Abstract][Full Text] [Related]
10. Electrolyzed-reduced water reduced hemodialysis-induced erythrocyte impairment in end-stage renal disease patients.
Huang KC; Yang CC; Hsu SP; Lee KT; Liu HW; Morisawa S; Otsubo K; Chien CT
Kidney Int; 2006 Jul; 70(2):391-8. PubMed ID: 16760903
[TBL] [Abstract][Full Text] [Related]
11. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein J/Clusterin is a novel structural component of human erythrocytes and a biomarker of cellular stress and senescence.
Antonelou MH; Kriebardis AG; Stamoulis KE; Trougakos IP; Papassideri IS
PLoS One; 2011; 6(10):e26032. PubMed ID: 21998749
[TBL] [Abstract][Full Text] [Related]
13. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation.
Morena M; Delbosc S; Dupuy AM; Canaud B; Cristol JP
Hemodial Int; 2005 Jan; 9(1):37-46. PubMed ID: 16191052
[TBL] [Abstract][Full Text] [Related]
14. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress.
Yang CC; Hsu SP; Wu MS; Hsu SM; Chien CT
Kidney Int; 2006 Feb; 69(4):706-14. PubMed ID: 16395251
[TBL] [Abstract][Full Text] [Related]
15. Blood modifications associated with end stage renal disease duration, progression and cardiovascular mortality: a 3-year follow-up pilot study.
Antonelou MH; Georgatzakou HT; Tzounakas VL; Velentzas AD; Kokkalis AC; Kriebardis AG; Papassideri IS
J Proteomics; 2014 Apr; 101():88-101. PubMed ID: 24549005
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
[TBL] [Abstract][Full Text] [Related]
17. A role for the membrane proteome in human chronic kidney disease erythrocytes.
Alvarez-Llamas G; Zubiri I; Maroto AS; de la Cuesta F; Posada-Ayala M; Martin-Lorenzo M; Barderas MG; Fernandez-Fernandez B; Ramos A; Ortiz A; Vivanco F
Transl Res; 2012 Nov; 160(5):374-83. PubMed ID: 22814359
[TBL] [Abstract][Full Text] [Related]
18. Reduced hemodialysis-induced oxidative stress in end-stage renal disease patients by electrolyzed reduced water.
Huang KC; Yang CC; Lee KT; Chien CT
Kidney Int; 2003 Aug; 64(2):704-14. PubMed ID: 12846769
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.
Westhuyzen J; Saltissi D; Stanbury V
Ann Clin Lab Sci; 2003; 33(1):3-10. PubMed ID: 12661892
[TBL] [Abstract][Full Text] [Related]
20. Plasma protein thiolation index (PTI) as a biomarker of thiol-specific oxidative stress in haemodialyzed patients.
Colombo G; Reggiani F; Podestà MA; Garavaglia ML; Portinaro NM; Milzani A; Badalamenti S; Dalle-Donne I
Free Radic Biol Med; 2015 Dec; 89():443-51. PubMed ID: 26453922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
